TMCnet News

Research and Markets: Worldwide Inherited Metabolic Disorders Pipeline Insights 2015
[July 30, 2015]

Research and Markets: Worldwide Inherited Metabolic Disorders Pipeline Insights 2015


Research and Markets (http://www.researchandmarkets.com/research/xrr2cs/inherited) has announced the addition of the "Inherited Metabolic Disorders-Pipeline Insights" report to their offering.

Inherited Metabolic Disorders - Pipeline Insights provides the in-depth analysis of the pipeline assets across the Inherited Metabolic Disorders. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Inherited Metabolic Disorders Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Inherited Metabolic Disorders - Pipeline Insights Reportcovers the Inherited Metabolic Disorders pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Inherited Metabolic Disorders related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Inherited Metabolic Disorders.



Scope

- The report provides a Inherited Metabolic Disorders Landscape across the globe


- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information

- Coverage of the Inherited Metabolic Disorders pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

- The report reviews key players involved in the therapeutics development for Inherited Metabolic Disorders and also provide company profiling

- Pipeline products coverage based on various stages of development from NDA filings to discovery.

- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

For more information visit http://www.researchandmarkets.com/research/xrr2cs/inherited


[ Back To TMCnet.com's Homepage ]